Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
08/2003
08/13/2003CN1435700A Electric filter for electronic display
08/13/2003CN1117750C 3-heterocyclyl-substd. benzoyl derivs.
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117741C Heterocyclic fungicides
08/13/2003CN1117568C Gastrokinetic bicyclie benzamides of 3-or 4-substd. 4-(aminomethyl)-piperidine derivs.
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605631 Ortho-substituted 2-methoxyiminophenyl-N-methylacetamides
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605623 Prevention of asthma and other allergic diseases
08/12/2003US6605618 Antidiabetic agents; hypoglycemic agents; anticholesterol agents; side effect reduction
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605608 Amino acid derivatives and drugs containing the same as the active ingredient
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605599 Epothilone derivatives
08/12/2003US6605255 Kit comprising a pharmaceutical composition containing repinotan or a physiologically acceptable salt of repinotan, and a means for the determination of the concentration of repinotan or its metabolites in body
08/07/2003WO2003064431A2 Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
08/07/2003WO2003064421A1 Aminopiperidine derivatives
08/07/2003WO2003064416A1 Heterocyclic tripeptides as hepatitis c inhibitors
08/07/2003WO2003064403A1 Furanone derivatives
08/07/2003WO2003064401A1 Acrylonitrile compounds and pest controllers
08/07/2003WO2003064397A1 Indazole compounds useful as protein kinase inhibitors
08/07/2003WO2003064385A2 Delta1-pyrrolines and their use as pest control agents
08/07/2003WO2003064369A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/07/2003WO2003063794A2 2,4-pyrimidinediamine compounds and their uses
08/07/2003WO2002051819A9 Heterocyclic compounds having antibacterial activity, process for their preparation and pharmaceutical compositions containing them
08/07/2003US20030149277 Triarylimidazole derivatives as cytokine inhibitors
08/07/2003US20030149267 Hydroformylating internal olefins with carbon monoxide and hydrogen in presence of diphosphine ligand to convert internal olefins to linear aldehydes with high selectivity
08/07/2003US20030149266 Administering to a patient (a warm blooded animal, such as man) an effective amount of a pyrimidine derivative for treating cancer, cell proliferation, and inhibition of focal adhesion kinase effect
08/07/2003US20030149093 For therapy of dyspepsia, early satiety, bloating and anorexia
08/07/2003US20030149086 EP4 receptor selective agonists in the treatment of osteoporosis
08/07/2003US20030149064 Pyrimidine compounds
08/07/2003US20030149063 For therapy of ras- oncogene-dependent tumors, such as cancers of pancreas, colon, bladder, and thyroid; useful for controlling metastasis, suppressing angiogenesis, inducing apoptosis, and Ras-associated proliferative diseases
08/07/2003US20030149057 Anti-cancer compounds
08/07/2003US20030149056 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/07/2003US20030149054 Administering thiazolidinedione derivatives for therapy and prophylaxis of cardiovascular diseases or eating disorders in a human or non- human mammal
08/07/2003US20030149048 For therapy of hyperproliferative disorder in a mammal
08/07/2003US20030149043 N-[(substituted five-membered di-or triaza diunsaturated ring)carbonyl] guanidine derivatives for the treatment of ischemia
08/07/2003US20030149039 For therapy of disease responsive to antagonist modulation of the Neurokinin-1 (NK-1) receptor in a patient
08/07/2003US20030149036 Substituted benzothiazole amide derivatives
08/07/2003US20030149035 For therapy and prophylaxis of infections by herpesviruses
08/07/2003US20030149034 Indazoles substituted with1,1-dioxoisothiazolidine useful as inhibitors of cell proliferation
08/07/2003US20030149029 Administering to a mammal indole derivative compound for therapy of asthma
08/07/2003US20030149014 Imidazo[4,5-b]-pyridinium-containing cephem compounds having broad antibacterial spectrum activity
08/07/2003US20030148890 Organic compounds
08/07/2003US20030145394 Helium-neon excitable reticulocyte dyes derivable from halolepidines
08/07/2003CA2474871A1 Furanone derivatives
08/07/2003CA2474594A1 Delta1-pyrrolines
08/07/2003CA2474277A1 2,4-pyrimidinediamine compounds and their uses
08/07/2003CA2473162A1 Novel thyroid hormone receptor ligand, medicinal compositions containing the same and use thereof
08/06/2003EP1332142A1 Sodium salts of 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]b enzyl]thiazolidine-2,4-dione
08/06/2003EP1332141A1 Quinazoline derivatives
08/06/2003EP1332136A2 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
08/06/2003EP1332133A1 Metabotropic glutamate receptor antagonists
08/06/2003EP1332131A2 Acid derivatives useful as serine protease inhibitors
08/06/2003EP0821674B1 Cyclic amidino agents useful as nitric oxide synthase inhibitors
08/06/2003EP0804419B1 Quinoline derivatives as tachykinin nk 3 receptor antagonists
08/06/2003EP0686632B1 Benzothiazine derivative
08/06/2003CN1434823A 3-thiazol-4-yl-pyprolidine derivatives as AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434822A Substituted oxazolidinones and their use in the field of blood coagulation
08/06/2003CN1434821A Quinazoline derivatives for the treatment of tumours
08/06/2003CN1434813A Pyrrolidine derivatives cyclic AMP-specific phosphodiesterase inhibitors
08/06/2003CN1434812A Thizaolyl amide derivatives
08/06/2003CN1434811A New p2†ù7 receptor antagonists for use in the treatment of inflammatory immune or cardiovascular diseases
08/06/2003CN1434806A Substituted imidazole neuropeptide YY5 receptor antagonists
08/06/2003CN1434802A New azabicyclooctane derivatives useful in the treatment of cardiac arrhythmias
08/06/2003CN1434801A Substited 8-anylquinoline phosphodiesterase-4 inhibitors
08/06/2003CN1117090C N-acryl-2-substituted-4-(benzimidazolyl-or-imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists
08/06/2003CN1117083C Pyradazin-3-one derivatives, their use, and intermediates for their production
08/06/2003CN1117082C Substituted imidazoles having anti-cancer and cytokine inhibitory activity
08/06/2003CN1117077C 6-phenylpyridyl-2-amine derivatives useful asNOS inhibitors
08/05/2003US6603023 Synthesis of epothilones, intermediates thereto and analogues thereof
08/05/2003US6603015 Antitumor agents; anticancer agents; malaria; Alzheimer's disease
08/05/2003US6603008 Sulfamoylheleroaryl pyrazole compounds as anti-inflammatory/analgesic agents
08/05/2003US6603005 Heterocyclylalkylpiperidine derivatives, their preparation and compositions containing them
08/05/2003US6602891 Muscarinic receptor agonists
08/05/2003US6602890 N-(3,5-dichloropyridin-4-yl)-2-(1-(4-fluorobenzyl)-5 -hydroxyindol-3-yl)-2-oxoacetamide, for example; treating eosinophil-related conditions, including chronic obstructive pulmonary disease
08/05/2003US6602885 Viricides, organ transplants, antiarthritic agents
08/05/2003US6602884 Quinolylpropylpiperidine derivatives, their preparation, and compositions containing them
08/05/2003US6602875 Sorbitol dehydrogenase inhibitors
08/05/2003US6602873 Angiogenesis inhibiting thiadiazolyl pyridazine derivatives
08/05/2003US6602871 Thrombin or factor Xa inhibitors
08/05/2003US6602867 Triazole compounds with dopamine-D3-receptor affinity
08/05/2003US6602864 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds
08/05/2003CA2264511C Compounds useful for inhibition of farnesyl protein transferase
08/01/2003CA2370400A1 Hepatitis c inhibitor tri-peptides
08/01/2003CA2369970A1 Hepatitis c inhibitor tri-peptides
07/2003
07/31/2003WO2003062388A2 Inhibition of rna function
07/31/2003WO2003062233A1 2-acylaminothiazole derivative or salt thereof
07/31/2003WO2003062232A1 Derivatives of thiazoles used for the treatment of neurological diseases
07/31/2003WO2003062231A1 Antimicrobial dihydrothiazine and dihydrothiopyran oxazolidinones
07/31/2003WO2003062224A1 Aza-cyclic compounds as modulators of acetylcholine receptors
07/31/2003WO2003062215A1 4(hetero-) aryl substituted (thia-/oxa-/pyra) zoles for inhibition of tie-2
07/31/2003WO2003062211A1 Pyrimidinone viral polymerase inhibitors
07/31/2003WO2003062209A2 Substituted quinazolin-4-ylamine analogues as modulators of capsaicin
07/31/2003WO2003062192A1 Cycloalkyl ketoamides derivatives useful as cathepsin k inhibitors
07/31/2003WO2003061655A1 2-aminothiazole allosteric enhancers of a1 adenosine receptors
07/31/2003WO2003045901A3 Guanidine derivatives
07/31/2003WO2003006495A3 Human papillomavirus e2 transactivation domain/inhibitor co-crystal and x-ray coordinates defining the inhibitor-binding pocket
07/31/2003WO2002060875A8 Nicotinamide biaryl derivatives useful as inhibitors of pde4 isozymes
1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 628